Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;29(1):114-116.
doi: 10.5021/ad.2017.29.1.114. Epub 2017 Feb 3.

Tuberculosis Cutis Orificialis in Adalimumab Related Immunosupressive Patient

Mehdi Iskandarli  1 , Bengu Gerceker Turk  1 , Banu Yaman  2 , Naim Ceylan  3 , Can Ceylan  1
Affiliations

Tuberculosis Cutis Orificialis in Adalimumab Related Immunosupressive Patient

Mehdi Iskandarli et al. Ann Dermatol. 2017 Feb.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. (A) Irregular, well-demarcated ulceration with pseudomembranous base on upper gingival mucosa. (B) Healed gingival ulceration following the nine month of antituberculous therapy.
Fig. 2
Fig. 2. (A) Millet seeds appearance of the lungs due to miliary tuberculous (TB) infection. (B) Hepatosplenomegaly as a manifestation of disseminated TB infection. (C) Enlarged lymph node (arrow) due to TB lymphadenitis.
Fig. 3
Fig. 3. (A) Single multinuclear Langhans type giant cell without granulomatous inflammation in tissue sample taken from gingiva (H&E, ×40). (B) Granulomatous inflammation in the excised lymph node (LN) (H&E, ×40). (C) Multinuclear Langhans type giant cells around granular formations in excised posterior triangule LN (H&E, ×10). (D) Giant cells and histiocytes around caseous necrosis (H&E, ×200).
See this image and copyright information in PMC

References

    1. Bravo FG, Gotuzzo E. Cutaneous tuberculosis. Clin Dermatol. 2007;25:173–180. - PubMed
    1. Turkmen M, Turk BG, Kandıloglu G, Dereli T. Tuberculosis cutis orificialis in an immunocompetent patient. Cutis. 2015;95:E4–E6. - PubMed
    1. Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A, et al. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR) Ann Rheum Dis. 2010;69:522–528. - PMC - PubMed
    1. Mohan AK, Coté TR, Block JA, Manadan AM, Siegel JN, Braun MM. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis. 2004;39:295–299. - PubMed
    1. Wallis RS. Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockade. Arthritis Rheum. 2008;58:947–952. - PubMed

LinkOut - more resources